Russia through the prism of the world biopharmaceutical market

Biotechnology Journal

Volumn 2, Issue 7, 2007, Pages 801-817

  Bairamashvili, Dmitrij I ^a   Rabinovich, Mikhail L ^b  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b BACH INSTITUTE OF BIOCHEMISTRY   (Russian Federation)

Author keywords

Biogenerics; Biopharmaceuticals; DLO; Insulin; Russian market

Indexed keywords

ACTRAPID NM; ADALIMUMAB; ALPHA INTERFERON; BASAL GT; BIGUANIDE; BLOOD CLOTTING FACTOR 8; ETANERCEPT; FOLLITROPIN; GLUCOSYLCERAMIDE; HUMAN GROWTH HORMONE; HUMAN INSULIN; HUMULIN M3; INFLIXIMAB; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; INSUMAN RAPID GT; INSURAN; ISOPHANE INSULIN; MIXTARD 30 NM; NEUTRAL INSULIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; NOVO RAPID; PALIVIZUMAB; PANITUMUMAB; PEGINTERFERON ALPHA2B; REAFERON EC; RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT HUMAN INSULIN; RITUXIMAB; SULFONYLUREA; UNCLASSIFIED DRUG; UNINDEXED DRUG; WART VIRUS VACCINE;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BIOTECHNOLOGY; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; DRUG INDUSTRY; DRUG MARKETING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; REVIEW; RUSSIAN FEDERATION; TREND STUDY;

BIOPHARMACEUTICS; BIOTECHNOLOGY; DRUG INDUSTRY; FINANCING, GOVERNMENT; MARKETING; RUSSIA;

EID: 34547444725     PISSN: 18606768     EISSN: None     Source Type: Journal    
DOI: 10.1002/biot.200700091     Document Type: Review

References (70)

1. Grimley, J., Pharma challenged. Chem. Eng. News 2006, 84, 17-28.
2. Hu, X., Ma, Q., Zhang, S., Biopharmaceuticals in China. Biotechnol. J. 2006, 1, 1215-1224.
3. Johnson, I. S., The trials and tribulations of producing the first genetically engineered drug. Nat. Rev Drug Discov. 2003, 2, 747-751.
4. Crea, R., Kraszewski, A., Hirose, T., Itakura, K., Chemical synthesis of genes for human insulin. Proc. Natl. Acad. Sci USA 1978, 75, 5764-5769.
5. Goeddel, D. V., Kleid, D. G., Bolivar, F., Heyneker, H. L. et al., Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc. Natl. Acad. Sci. USA 1979, 76, 106-110.
6. Miller, W. L., Baxter, J. D., Recombinant DNA - a new source of insulin. Diabetologia 1980, 18, 431-436.
7. Clark, A. J., L., Knight, G., Whiles, P. G., Keen, H. et al., Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients. Lancet 1982, 320, 354-357.
8. Voltarelli; J. C., Couri; C. E. B., Stracieri; A. B. P. L., Oliveira; M. C. et al., Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. J. Am. Med. Assoc. 2007, 297, 1568-1576.
9. Skyler, J. S., Cellular therapy for type 1 diabetes: has the time come? J. Am. Med. Assoc. 2007, 297, 1599-1600.
10. Bibby, K., Davis, J., Jones, C., Biopharmaceuticals - Moving to centre stage. 2003 BioPeople North American Biotechnology Industry and Suppliers' Guide. IMS Global website 3-11, 2003 http://www.imshealth.com/vgn/images/portal/cit_40000873/ 43028586Bio_Moving_to_Centre_Stage.pdf (30 October 2006).
11. Walsh, G., Biopharmaceutic benchmarks-2006. Nat. Biotechnol. 2006, 24, 769-776.
12. Nightingale, P., Martin, P. The myth of the biotech revolution. Trends Biotechnol. 2004, 22, 564-569.
13. Krasilnikov, I. V., Prospects of development of recombinant pharmaceutical market (in Russian). Farmacevt. vestnik 2005, 16, 26 (http://www.pharmvestnik.ru/cgi-bin/statya.pl?sid=9868).
14. Devine, J. W., Cline, R. R., Farley, J. F., Follow-on biologics: competition in the biopharmaceutical marketplace. J. Am. Pharm. Assoc. 2006, 46, 193-204.
15. Wick, J. Y., Zanni, G. R., Biogenerics: potential benefits and obstacles. Consult Pharm. 2006, 21, 208-221.
16. Bartoshevich, I. E., Nys, P. S., Shviadas, V. I., Navashin, S. M., Status and prospects in the use of biocatalysis in the synthesis of β-lactam antibiotics (in Russian). Antibiot. Med. Biotekhnol. 1986, 31, 98-104.
17. Chazov, E. I., Smirnov, V. N., Suvorova, L. A., Suvorov, A. V. et al., Effect of the new Soviet thrombolytic preparation streptodecase on the fibrmolysis system (in Russian). Kardiologiia 1981, 21, 18-21.
18. Ovchinnikov, Y. A., Efimov, V. A., Chakhmakhcheva, O. G., Synthesis of a polynucleotide corresponding to the promotor region of bacteriofage fd DNA. FEBS Lett. 1979, 100, 341-346.
19. Ovchinnikov, Y. A., Efimov, V. A., Ivanova, I. N., Synthesis of DNA coding for human proinsulin. Gene 1984, 31, 65-78.
20. Debabov, V. G., Tsygankov, Ju. D., Chistoserdov, A. Ju., Sverdlov, E. D., et al. Method for producing human leukocyte interferon α-2 Pat. SU1364343, 1988
21. Pokrovskii, V. I., Zmyzgova, A. V., Murzabaeva, R. T., Fomina, T. N. et al., Reactogenicity, toxicity and tolerance of reaferon in healthy volunteers (in Russian). Zh. Mikrobiol. Epidemiol. Immunobiol. 1988, 1, 69-73.
22. Gabrilovich, D. I., Serebrovskaia, L. V., Murzabaeva, R. T., Semashko, M. I. et al., Effect of reaferon on the functional activity of peripheral blood lymphocytes and neutrophils of volunteers (in Russian). Zh. Mitcrobiol. Epidemiol. Immunobiol. 1988, 3, 61-65.
23. Malinovskaia, V. V., Murzabaeva, R. T., Manakhova, L. S., Mironova, L. L., The functioning of the interferon system with different methods and dosages of recombinant α 2-interferon (reaferon) administration (in Russian). Vopr. Virusol. 1989, 34, 180-183.
24. Pisarev, V. V., Does Russia have a chance of implementation of modern biotech achievements in the medical industry? (in Russian). Remedium 2004, 4, 29-33, www.bionews.ru/news/Bio.htm
25. Grigoriev, A. I., Malashenkov, D. K., The role of innovation in the development of life sciences (in Russian). Medbioteck-3, December, 2006, Moscow (http://www.bioinnovation.ru/index?id=materials).
26. Tel'nova, E., "Toll-free" prescription has become more expensive (in Russian). Rossijskaya Gazeta 21.10.2006. 237, 19 (http://www.rg.ru).
27. Fast growth of pharmaceutical market (in Russian). Moskovskie apteki, 25.12.2006 (http://www.mosapteki.ru/modules/news/ article.php?storyid=202).
28. Stepanov, V. Doctor "Brand" (in Russian). SmartMoney 04.09.2006, 25 (25) (www.smoney.m/article.shtml?2006/09/04/1255).
29. DLO: Market and patient (in Russian). Moskovskie apteki. 2006, 7-8 (152), 7-11 (http://www.mosapteki.ru).
30. Konov, A. L., Biopharmaceuticals: state-of-the-art and perspectives (in Russian). Farmacevt. sluzhba 2006, 1, 22-29.
31. Kulish, D. M., Can a "biogeneric revolution" happen in Russia? (in Russian) Farmacevt. vestnik 2005, 16 (375), 26 (http://www.pharmvestnik.ru/cgi-bin/statya.pl?sid=9570).
32. Schmidt, M., Babu, K. R., Khanna, N., Marten, S. et al., Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli. J. Biotechnol. 1999, 68, 71-83.
33. Kostina, G., Russian pancreas functions badly (in Russian). Expert 2007, 13, 60 (http://www.expert.ru).
34. Vasiliev, F., Realization of the DLO Program in the first half of 2006 (in Russian). Farmacevt. vestnik, 2006, 30 (435) (http://www.pharmvestnik.ru/cgi-bin/statya.pl?sid=11278&forprint=1).
35. Bairamashvili, D. I., Genetic-engineering insulin of human: successes and prospects (in Russian). Ross. Khim. Zh. (Zh. Ross. Khim. Obshchestva im. D.I.Mendeleeva) 2005, 49, 34-46.
36. Korobko, V. G., Boldyreva, E. F., Shingarova, L. N., Miroshnikov, A. I. et al., Recombinant plasmid DNA pPINS1-6 encoding fused polypeptide containing human proinsulin, recombinant plasmid DNA pPINS2-5 encoding fused polypeptide containing human proinsulm and strain of bacterium Escherichia coli - producer of fused polypeptide containing human proinsulin. Pat. RU2143493, 1999.
37. Kalinin, Yu. T., Urakov, N. N., Ivanov, V. T., Stepanov, A. V. et al., Method of recombinant human insulin preparing. Pat. RU2141531, 1999.
38. Pustoshilova, N. M., Kileva, E. V., Denisova, L. J., Shingareva, N. V. et al., Method of human recombinant tumor necrosis α-factor preparing. Pat. RU2144958, 2000.
39. Patrushev L. I., Bairamashvili, D. I., Miroshnikov, A. I., Bacterium Escherictna coli strain BL21/pPINS07(BL07) as producer of human proinsulin. Pat. RU2267534, 2006.
40. Gusarov, D., Lasman, V., Bobruskin, A., Bairamashvili, D., Pilot plant scale purification of the human insulin and human growth hormone by reversed phase HPLC and hydrophobic interaction chromatography: Methods comparison and qualification. Abstracts of the 5th HIC/RPC Bioseparation Conference, 20-23 March 2007, Interlaken, Switzerland., p. 68.
41. Vorobyov, I. I., Ponomarenko, N. A., Alexandrova, E. S., Murashev, E. A. et al., Highly efficient process of human growth hormone production. Russian Biotechnol. 2005, 5, 44-48.
42. Gabibov, A. G., Ponomarenko, N. A., Vorobyev, I. I., Demm, A. V. et al., Recombinant plasmid DNA pES1-6 encoding polypeptide somatotropin and strain Escherichia coli BL21(DE3)/pES1-6 as producer of recombinant somatotropin. Pat. RU2233879, 2004.
43. Gabibov, A. G., Ponomaremko, N. A., Vorobyev, I. I., Demin, A. V. et al., Recombinant plasmid DNA pES3-7 encoding polypeptide sequence of human granulocyte colony stimulating factor and strain Escherichia coli BL21(DE3)/pES3-7 as producer of recombinant human granulocyte colony stimulating factor. Pat. RU2260049, 2005.
44. Klyushnichenko, V., Bruch, R., Bulychev, A., Ditsch, A. et al., Feasibility of international technology transfer for the production of recombinant human insulin. Part 2. Two models for insulin manufacturing in Russia. BioProcess Int. 2004, 2, 46-54.
45. Stepanov, A. V., Rodionov, P. P., Baydus', A. N., Astashkina, G. F., Domestic insulin - product of the world quality level (in Russian). Terra Medica Nova 2005, 1, 48-49.
46. Valuev, I. L., Valuev, L. I., Plate, N. A., Mechanism of action of immobilized insulin preparations for oral administration. Dokl. Phys. Chem. 1998, 360, 131-134.
47. Plate, N. A., Valuev, L. I., Valueva, T. A., Staroseltseva L. K. et al., Protein-containing polymer composition for oral administration. Pat. US6004583, 1999.
48. Mukamolova, G. V., Kaprelyants, A. S., Young, D. I., Young, M. et al., A bacterial cytokine. Proc. Natl. Acad. Sci. USA 1998, 95 , 8916-8921.
49. Yeremeev, V. V., Kondratieva, T. K., Rubakova, E. I., Petrovskaya, S. N. et al., Proteins of the Rpf family: Immune cell reactivity and vaccination efficacy against tuberculosis in mice. Infect. Immun. 2003, 71, 4789-4794.
50. Kudoyarova-Zubavichene, N. M., Sergeyev, N. N., Chepurnev, A. A., Netesov, S. M, Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola vires infections. J. Infect. Dis. 1999, 179 (Suppl. 1), S218-S223.
51. Kiselev, O. I., Tsybalova, L. M., Pokrovskii, V. I., Development of the anti-influenza H5N1 vaccines worldwide and in Russia (in Russian). Zh. Mikrobiol. Epidemiol. Immunobiol. 2006, 5, 28-38.
52. Avdeeva, Zh. I., Alpatova, I. A., Medunitsyn, N. V., Pharmaceuticals of cytokine system (in Russian). Citokiny i vospalenie 2002, 1, 33.
53. Simbirtsev, A. S., Cytokines as mediators of defence reactions of the organism (in Russian). Citokiny i vospalenie 2002, 1, 38-39.
54. Suchkov, S. V., Alekberova, Z. S., Paleyev, F. N., Naumova, T. Y. et al., Achievements and prospects of clinical abzymology (in Russian). Vestnik Ros. Akad. Med. Nauk 2005, 9, 38-43.
55. Baryshnikov, A. I., Sviridov, V. V., Russian collection of hybridomas (in Russian). Vestnik Ros. Akad. Med. Nauk 1999, 10, 30-32.
56. Chmutin, Y. F., Ivanov, P. K., Baryshnikov, A. Y., Monoclonal antibody-based design of antitumor drugs: Prerequisites and progress (in Russian). Vestmk Ros. Akad. Med. Nauk 2004, 12, 10-16.
57. Baryshnikov, A. I., Polosukhina, E. R., Monoclonal antibodies in oncology (in Russian). Vestnik Ros. Akad. Med. Nauk 2001, 9, 14-18.
58. Stadnikov, A. A., Shevliuk, N. N., Stem cells and reparative regeneration in mammalian postnatal ontogenesis (in Russian). Morfologiia (St. Petersburg, Russia), 2006, 130, 84-88.
59. Korochkin, L. I., Revishchin, A. V., Okhotin, V. E., Neural stem cells and their role in recovery processes in the nervous system. Neurosci. Behavioral Physiol. 2006, 36, 499-512.
60. Baranov, V. S., Genomics and molecular medicine. Mol. Biol. 2004, 38, 94-99.
61. Shishkin, S. S., From structural to functional genomics: theoretical and applied aspects (in Russian). Vestnik Ros. Akad. Med. Nauk 2002, 4, 11-16.
62. Baranov, V. S., Baranov, A. N., Zelenin, A. V., The current state and prospects of the gene therapy of duchenne muscular dystrophy worldwide and in Russia. Russian J. Genet. 2001, 37, 868-875.
63. Vlasov, V. V., Oligonucleotides as the basis of gene-targeted therapeutic drugs. Herald Russ. Acad. Sci. 2004, 74, 419-423.
64. Zhdanov, R. I., Bogdanenko, E. V., Petrov, A. I., Podobed, O. V. et al., Lipoplexes based on cholesterol derivatives of oligo (ethylene propylene imines) in gene transfer in vitro and in vivo. Dokl. Biochem. Biophys. 2005, 401, 131-135.
65. Bogdanenko, E. V., Zhdanov, R. I., Sebyakin, Y. L., Zarubina, T. V. et al., A glycolipid containing a lactose residue: a novel agent for targeted DNA delivery for the purpose of genetic therapy. Dokl. Biochem. Biophys. 2005, 401, 145-149.
66. Petrov, R. V., Kabanov, V. A., Khaitov, R. M., Nekrasov, A. V. et al., Conjugated polymer-subunit immunogens and vaccines. Allergy Clin. Immanol. Int. 2003, 15, 56-61.
67. Sobolev, B. N., Poroikov, V. V., Olenina, L. V., Kolesanova, E. F. et al., Computer-aided design of vaccines (in Russian). Biomed. Khim. 2003, 49, 309-332.
68. Gorokhovets, N. V., Digtjar, A. V., Lutsenko, E. V., Lutsenko, S. V. et al., Antitumor peptide preparation based on α-fetoprotein fragment, its conjugate, pharmaceutical composition and method for treatment of hormone-dependent tumors. Pat. RU2285537, 2006.
69. Surovtsev, V., Baryshnikova, G., RFT will help to revive production of the most important pharmaceutical substances (in Russian). Farmacevt. Vestnik 2007, 12, 14 (http://www.pharmvestnik.ru/cgi-bin/ statya.pl?sid=11977).
70. Pharmaceutical industry needs preferences (in Russian). Moskovskie apteki, 2007, 4 (http://www.mosapteki.m/modules/news/ article.php?storyid=254).